FI920934A0 - Komposition för stabilisering av blodplasma under pastörisering - Google Patents

Komposition för stabilisering av blodplasma under pastörisering

Info

Publication number
FI920934A0
FI920934A0 FI920934A FI920934A FI920934A0 FI 920934 A0 FI920934 A0 FI 920934A0 FI 920934 A FI920934 A FI 920934A FI 920934 A FI920934 A FI 920934A FI 920934 A0 FI920934 A0 FI 920934A0
Authority
FI
Finland
Prior art keywords
composition
blood plasma
stabilizing blood
plasma during
during pasteurization
Prior art date
Application number
FI920934A
Other languages
English (en)
Finnish (fi)
Other versions
FI96918B (sv
FI96918C (sv
Inventor
Miryana Burnouf-Radosevich
Thierry Burnouf
Original Assignee
Centre Regional De Transfusion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Regional De Transfusion filed Critical Centre Regional De Transfusion
Publication of FI920934A0 publication Critical patent/FI920934A0/sv
Publication of FI96918B publication Critical patent/FI96918B/sv
Application granted granted Critical
Publication of FI96918C publication Critical patent/FI96918C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6443—Coagulation factor XIa (3.4.21.27)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21027—Coagulation factor XIa (3.4.21.27)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI920934A 1990-07-03 1992-03-02 Komposition för stabilisering av blodplasma under pastörisering FI96918C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9008375A FR2664165B1 (fr) 1990-07-03 1990-07-03 Composition pour stabiliser le plasma sanguin en cours de pasteurisation.
FR9008375 1990-07-03
PCT/FR1991/000493 WO1992000767A1 (fr) 1990-07-03 1991-06-20 Composition pour stabiliser le plasma sanguin en cours de pasteurisation
FR9100493 1991-06-20

Publications (3)

Publication Number Publication Date
FI920934A0 true FI920934A0 (sv) 1992-03-02
FI96918B FI96918B (sv) 1996-06-14
FI96918C FI96918C (sv) 1996-09-25

Family

ID=9398269

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920934A FI96918C (sv) 1990-07-03 1992-03-02 Komposition för stabilisering av blodplasma under pastörisering

Country Status (22)

Country Link
EP (1) EP0497929B1 (sv)
JP (1) JP3132828B2 (sv)
AT (1) ATE135238T1 (sv)
AU (1) AU8062991A (sv)
CA (1) CA2065284A1 (sv)
CZ (1) CZ281431B6 (sv)
DE (1) DE69117920T2 (sv)
DK (1) DK0497929T3 (sv)
ES (1) ES2084821T3 (sv)
FI (1) FI96918C (sv)
FR (1) FR2664165B1 (sv)
GR (1) GR3020048T3 (sv)
HU (1) HU208404B (sv)
LT (1) LT3419B (sv)
LV (1) LV10384B (sv)
NO (1) NO179127C (sv)
PL (1) PL166579B1 (sv)
PT (1) PT98190B (sv)
RU (1) RU2045902C1 (sv)
SK (1) SK279031B6 (sv)
WO (1) WO1992000767A1 (sv)
ZA (1) ZA914848B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2687317B1 (fr) 1992-02-13 1995-06-23 Aetsrn Composition pour stabiliser le plasma sanguin en cour de pasteurisation et solution plasmatique pasteurisee a usage therapeutique.
DE4240103A1 (de) * 1992-05-26 1993-12-02 Behringwerke Ag Verfahren zur Inaktivierung von Viren in Präparationen von Proteinen
DE19508192A1 (de) * 1995-03-09 1996-09-12 Behringwerke Ag Stabile Transglutaminasepräparate und Verfahren zu ihrer Herstellung
US20060019234A1 (en) * 2004-07-22 2006-01-26 Shanbrom Technologies, Llc Modern blood banking employing improved cell preservation composition
US11682319B2 (en) 2016-03-10 2023-06-20 Intuitive Surgical Operations, Inc. Fake blood for use in simulated surgical procedures

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2916711A1 (de) 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
EP0035204B2 (en) 1980-03-05 1991-05-22 Miles Inc. Pasteurized therapeutically active protein compositions
DE3045153A1 (de) * 1980-11-29 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x
DE3336631A1 (de) * 1983-10-08 1985-04-18 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von plasma oder von konzentraten der blutgerinnungsfaktoren ii, vii, ix und x
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
DK18288D0 (da) * 1988-01-15 1988-01-15 Nordisk Gentofte Fremgangsmaade til pasteurisering af vandige oploesninger af faktor viii

Also Published As

Publication number Publication date
ATE135238T1 (de) 1996-03-15
NO179127B (no) 1996-05-06
FI96918B (sv) 1996-06-14
ZA914848B (en) 1992-04-29
SK279031B6 (sk) 1998-05-06
PL294037A1 (en) 1993-01-11
FR2664165A1 (fr) 1992-01-10
WO1992000767A1 (fr) 1992-01-23
HUT60148A (en) 1992-08-28
PL166579B1 (pl) 1995-06-30
LV10384A (lv) 1995-02-20
GR3020048T3 (en) 1996-08-31
DE69117920T2 (de) 1996-10-02
RU2045902C1 (ru) 1995-10-20
PT98190A (pt) 1992-05-29
ES2084821T3 (es) 1996-05-16
CA2065284A1 (fr) 1992-01-04
NO920791D0 (no) 1992-02-28
EP0497929A1 (fr) 1992-08-12
CS57992A3 (en) 1992-08-12
DE69117920D1 (de) 1996-04-18
CZ281431B6 (cs) 1996-09-11
LT3419B (en) 1995-09-25
PT98190B (pt) 1998-12-31
AU8062991A (en) 1992-02-04
EP0497929B1 (fr) 1996-03-13
HU9200701D0 (en) 1992-05-28
JP3132828B2 (ja) 2001-02-05
NO179127C (no) 1996-08-14
JPH05501417A (ja) 1993-03-18
DK0497929T3 (da) 1996-07-22
LV10384B (en) 1995-04-20
FI96918C (sv) 1996-09-25
LTIP264A (en) 1994-10-25
FR2664165B1 (fr) 1992-10-16
NO920791L (no) 1992-02-28
HU208404B (en) 1993-10-28

Similar Documents

Publication Publication Date Title
ATE269290T1 (de) Benzoylderivate
NO832977L (no) Pasteurisert human-fibrinogen (hf), fremgangsmaate til dets fremstilling og dets anvendelse
FI882129A (fi) Preparat med antimikrobisk verkan.
DK0556096T3 (da) Præparat til stabilisering af blodplasma under pasteurisering samt pasteuriseret plasmaopløsning til terapeutisk brug
RU93004727A (ru) Состав для стабилизации плазмы крови, способ пастеризации плазмы и использование стабилизированной плазмы в терапии
DK406184D0 (da) Fremgangsmaade til pasteurisering af humanplasma
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
DK418986D0 (da) Pyrrolobenzimidazoler, pyrrolobenzoxazoler og pyrrolobenzthiazoler, fremgangsmaader til fremstilling heraf og laegemidler med indhold heraf
FI920934A0 (sv) Komposition för stabilisering av blodplasma under pastörisering
ATE129895T1 (de) Behandlung von pulmonarer disfunktion mit 15-keto-prostaglandin-derivaten.
DE3464486D1 (en) Derivatives of n-(4-acetylaminophenacyl)-amine, their therapeutical use and process for their preparation
ITAP930004U1 (it) Sistema di correzione del procurvato e del recurvato per allungatori di arti

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: L ÉTABLISSEMENT FRANçAIS DU SANG

Free format text: L ÉTABLISSEMENT FRANçAIS DU SANG

MA Patent expired